Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Submitted on August 11, 2004
Accepted on October 22, 2004
Human Prion Protein with Valine 129 Prevents Expression of Variant CJD Phenotype
Jonathan D. F. Wadsworth 1, Emmanuel A. Asante 1, Melanie Desbruslais 1, Jacqueline M. Linehan 1, Susan Joiner 1, Ian Gowland 1, Julie Welch 1, Lisa Stone 1, Sarah E. Lloyd 1, Andrew F. Hill 1, Sebastian Brandner 1, John Collinge 1*
1 Medical Research Council (MRC) Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK.
* To whom correspondence should be addressed.
John Collinge , E-mail: j.collinge{at}prion.ucl.ac.uk
Present address: Department of Biochemistry and Molecular Biology and Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia.
Variant Creutzfeldt-Jakob disease (vCJD) is a unique and highlydistinctive clinicopathological and molecular phenotype of humanprion disease associated with infection with bovine spongiformencephalopathy (BSE)-like prions. Here, we found that generationof this phenotype in transgenic mice required expression ofhuman prion protein (PrP) with methionine 129. Expression ofhuman PrP with valine 129 resulted in a distinct phenotype and,remarkably, persistence of a barrier to transmission of BSE-derivedprions on subpassage. Polymorphic residue 129 of human PrP dictatedpropagation of distinct prion strains after BSE prion infection.Thus, primary and secondary human infection with BSE-derivedprions may result in sporadic CJD-like or novel phenotypes inaddition to vCJD, depending on the genotype of the prion sourceand the recipient.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Robin W. Carrell (3 December 2004) Science306 (5702), 1692.
[DOI: 10.1126/science.1106679] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Novel Protective Prion Protein Variant that Colocalizes with Kuru Exposure.
S. Mead, J. Whitfield, M. Poulter, P. Shah, J. Uphill, T. Campbell, H. Al-Dujaily, H. Hummerich, J. Beck, C. A. Mein, et al. (2009)
N. Engl. J. Med.
361, 2056-2065
|Abstract »|Full Text »|PDF »
Prions: Protein Aggregation and Infectious Diseases.
Prion Protein-Detergent Micelle Interactions Studied by NMR in Solution.
S. Hornemann, C. von Schroetter, F. F. Damberger, and K. Wuthrich (2009)
J. Biol. Chem.
284, 22713-22721
|Abstract »|Full Text »|PDF »
Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
E. A. Asante, I. Gowland, A. Grimshaw, J. M. Linehan, M. Smidak, R. Houghton, O. Osiguwa, A. Tomlinson, S. Joiner, S. Brandner, et al. (2009)
J. Gen. Virol.
90, 546-558
|Abstract »|Full Text »|PDF »
Crystal structure of human prion protein bound to a therapeutic antibody.
S. V. Antonyuk, C. R. Trevitt, R. W. Strange, G. S. Jackson, D. Sangar, M. Batchelor, S. Cooper, C. Fraser, S. Jones, T. Georgiou, et al. (2009)
PNAS
106, 2554-2558
|Abstract »|Full Text »|PDF »
Genetic susceptibility, evolution and the kuru epidemic.
S. Mead, J. Whitfield, M. Poulter, P. Shah, J. Uphill, J. Beck, T. Campbell, H. Al-Dujaily, H. Hummerich, M. P Alpers, et al. (2008)
Phil Trans R Soc B
363, 3741-3746
|Abstract »|Full Text »|PDF »
The origin of the prion agent of kuru: molecular and biological strain typing.
J. D.F Wadsworth, S. Joiner, J. M Linehan, E. A Asante, S. Brandner, and J. Collinge (2008)
Phil Trans R Soc B
363, 3747-3753
|Abstract »|Full Text »|PDF »
Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease.
S. Brandner, J. Whitfield, K. Boone, A. Puwa, C. O'Malley, J. M Linehan, S. Joiner, F. Scaravilli, I. Calder, M. P. Alpers, et al. (2008)
Phil Trans R Soc B
363, 3755-3763
|Abstract »|Full Text »|PDF »
Implications for Creutzfeldt-Jakob Disease (CJD) in Dentistry: a Review of Current Knowledge.
J.T. Walker, J. Dickinson, J.M. Sutton, P.D. Marsh, and N.D.H. Raven (2008)
Journal of Dental Research
87, 511-519
|Abstract »|Full Text »|PDF »
Evaluation of the Human Transmission Risk of an Atypical Bovine Spongiform Encephalopathy Prion Strain.
Q. Kong, M. Zheng, C. Casalone, L. Qing, S. Huang, B. Chakraborty, P. Wang, F. Chen, I. Cali, C. Corona, et al. (2008)
J. Virol.
82, 3697-3701
|Abstract »|Full Text »|PDF »
Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.
J. D. F. Wadsworth, S. Joiner, J. M. Linehan, M. Desbruslais, K. Fox, S. Cooper, S. Cronier, E. A. Asante, S. Mead, S. Brandner, et al. (2008)
PNAS
105, 3885-3890
|Abstract »|Full Text »|PDF »
The elk PRNP codon 132 polymorphism controls cervid and scrapie prion propagation.
K. M. Green, S. R. Browning, T. S. Seward, J. E. Jewell, D. L. Ross, M. A. Green, E. S. Williams, E. A. Hoover, and G. C. Telling (2008)
J. Gen. Virol.
89, 598-608
|Abstract »|Full Text »|PDF »
Creutzfeldt-Jakob Disease, Prion Protein Gene Codon 129VV, and a Novel PrPSc Type in a Young British Woman.
S. Mead, S. Joiner, M. Desbruslais, J. A. Beck, M. O'Donoghue, P. Lantos, J. D. F. Wadsworth, and J. Collinge (2007)
Arch Neurol
64, 1780-1784
|Abstract »|Full Text »|PDF »
A General Model of Prion Strains and Their Pathogenicity.
Cross-sequence Transmission of Sporadic Creutzfeldt-Jakob Disease Creates a New Prion Strain.
A. Kobayashi, M. Asano, S. Mohri, and T. Kitamoto (2007)
J. Biol. Chem.
282, 30022-30028
|Abstract »|Full Text »|PDF »
Inherited prion disease with 5-OPRI: Phenotype modification by repeat length and codon 129.
S. Mead, T. E. F. Webb, T. A. Campbell, J. Beck, J. M. Linehan, S. Rutherfoord, S. Joiner, J. D. F. Wadsworth, J. Heckmann, S. Wroe, et al. (2007)
Neurology
69, 730-738
|Abstract »|Full Text »|PDF »
A Bovine Prion Acquires an Epidemic Bovine Spongiform Encephalopathy Strain-Like Phenotype on Interspecies Transmission.
V. Beringue, O. Andreoletti, A. Le Dur, R. Essalmani, J.-L. Vilotte, C. Lacroux, F. Reine, L. Herzog, A.-G. Biacabe, T. Baron, et al. (2007)
J. Neurosci.
27, 6965-6971
|Abstract »|Full Text »|PDF »
Defective Retrotranslocation Causes Loss of Anti-Bax Function in Human Familial Prion Protein Mutants.
J. Jodoin, S. Laroche-Pierre, C. G. Goodyer, and A. C. LeBlanc (2007)
J. Neurosci.
27, 5081-5091
|Abstract »|Full Text »|PDF »
Role of the GALT in Scrapie Agent Neuroinvasion from the Intestine.
Prion infectivity in variant Creutzfeldt-Jakob disease rectum.
J D F Wadsworth, S Joiner, K Fox, J M Linehan, M Desbruslais, S Brandner, E A Asante, and J Collinge (2007)
Gut
56, 90-94
|Abstract »|Full Text »|PDF »
Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity..
S. Mead, M. Poulter, J. Beck, T. E. F. Webb, T. A. Campbell, J. M. Linehan, M. Desbruslais, S. Joiner, J. D. F. Wadsworth, A. King, et al. (2006)
Brain
129, 2297-2317
|Abstract »|Full Text »|PDF »
Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation..
P. A. Lewis, M. H. Tattum, S. Jones, D. Bhelt, M. Batchelor, A. R. Clarke, J. Collinge, and G. S. Jackson (2006)
J. Gen. Virol.
87, 2443-2449
|Abstract »|Full Text »|PDF »
Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice.
E. A. Asante, J. M. Linehan, I. Gowland, S. Joiner, K. Fox, S. Cooper, O. Osiguwa, M. Gorry, J. Welch, R. Houghton, et al. (2006)
PNAS
103, 10759-10764
|Abstract »|Full Text »|PDF »
Influence of Homozygosity for Methionine at Codon 129 of the Human Prion Gene on the Onset of Neurological and Hepatic Symptoms in Wilson Disease..
Childhood Onset in Familial Prion Disease With a Novel Mutation in the PRNP Gene..
E. Rogaeva, C. Zadikoff, J. Ponesse, G. Schmitt-Ulms, T. Kawarai, C. Sato, S. Salehi-Rad, P. St. George-Hyslop, and A. E. Lang (2006)
Arch Neurol
63, 1016-1021
|Abstract »|Full Text »|PDF »
Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein.
J. D. F. Wadsworth, S. Joiner, J. M. Linehan, S. Cooper, C. Powell, G. Mallinson, J. Buckell, I. Gowland, E. A. Asante, H. Budka, et al. (2006)
Brain
129, 1557-1569
|Abstract »|Full Text »|PDF »
Role of N-terminal Familial Mutations in Prion Protein Fibrillization and Prion Amyloid Propagation in Vitro.
E. M. Jones, K. Surewicz, and W. K. Surewicz (2006)
J. Biol. Chem.
281, 8190-8196
|Abstract »|Full Text »|PDF »
Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations.
A. F. Hill, S. Joiner, J. A. Beck, T. A. Campbell, A. Dickinson, M. Poulter, J. D. F. Wadsworth, and J. Collinge (2006)
Brain
129, 676-685
|Abstract »|Full Text »|PDF »
Detection of Type 1 Prion Protein in Variant Creutzfeldt-Jakob Disease.
H. M. Yull, D. L. Ritchie, J. P.M. Langeveld, F. G. van Zijderveld, M. E. Bruce, J. W. Ironside, and M. W. Head (2006)
Am. J. Pathol.
168, 151-157
|Abstract »|Full Text »|PDF »
Low frequency of PrP genotype 225SF among free-ranging mule deer (Odocoileus hemionus) with chronic wasting disease.
J. E. Jewell, M. M. Conner, L. L. Wolfe, M. W. Miller, and E. S. Williams (2005)
J. Gen. Virol.
86, 2127-2134
|Abstract »|Full Text »|PDF »
The prion gene is associated with human long-term memory.
A. Papassotiropoulos, M. A. Wollmer, A. Aguzzi, C. Hock, R. M. Nitsch, and D. J.-F. de Quervain (2005)
Hum. Mol. Genet.
14, 2241-2246
|Abstract »|Full Text »|PDF »
Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
V. Lewis, A. F. Hill, G. M. Klug, A. Boyd, C. L. Masters, and S. J. Collins (2005)
Neurology
65, 113-118
|Abstract »|Full Text »|PDF »